VanEck Biotech Ownership
| BBH Etf | USD 160.00 2.46 1.51% |
VanEck |
VanEck Etf Ownership Analysis
VanEck Biotech is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Van Eck Associates Corporation. The fund has 26 constituents with avarage daily trading value of 7.7 K. The fund charges 0.35 percent management fee with a total expences of 0.35 percent of total asset. The fund holds 99.96% of assets under management (AUM) in equities. VanEck Biotech ETF last dividend was 0.472 per share. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States. For more info on VanEck Biotech ETF please contact the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on VanEck Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding VanEck Biotech , and the less return is expected.
Investment Allocations (%)
Top Etf Constituents
| ILMN | Illumina | Stock | |
| VRTX | Vertex Pharmaceuticals | Stock | |
| REGN | Regeneron Pharmaceuticals | Stock | |
| NVAX | Novavax | Stock | |
| MRNA | Moderna | Stock | |
| IQV | IQVIA Holdings | Stock | |
| INCY | Incyte | Stock | |
| GILD | Gilead Sciences | Stock | |
| GH | Guardant Health | Stock | |
| EXAS | EXACT Sciences | Stock | |
| CRL | Charles River Laboratories | Stock | |
| BMRN | Biomarin Pharmaceutical | Stock | |
| BIIB | Biogen Inc | Stock | |
| AMGN | Amgen Inc | Stock |
VanEck Biotech Outstanding Bonds
VanEck Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. VanEck Biotech ETF uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most VanEck bonds can be classified according to their maturity, which is the date when VanEck Biotech ETF has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Currently Active Assets on Macroaxis
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.